SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 21, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $170K total
Actionable Insight • Neutral

This cluster is too small to warrant a bearish read-through. Monitor for any C-suite open-market sales exceeding 0.1% of market cap, which would be a more meaningful signal. The next catalyst to watch is the upcoming quarterly earnings release for pipeline and revenue updates.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$24.78
T+0 close · Aug 21, 2026 · via day close
Latest settled
+12.11%
T+20 · $27.78 · next T+60 in 8h
Vs SPY
+10.81%
α at T+20
Latest observation
+27.00%
T+57 · FF3 residual α
  1. T+0 · Aug 24 $24.78entry
  2. T+1 · 3mo ago +0.32%α +0.00% · $24.86
  3. T+5 · 3mo ago −3.27%α −3.74% · $23.97
  4. T+20 · 8w ago +12.11%α +10.81% · $27.78
  5. T+59 · todayOpen
  6. T+60 · in 8h Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Arcutis Biotherapeutics sold a combined $170K in open-market sales over a week. Director Welgus Howard G. also exercised multiple derivative tranches for a net cash outlay of ~$32K, then sold the resulting shares at market prices. The total dollar value is only ~0.005% of ARQT's $3.2B market cap, making this a trivial cluster by proportionality standards. The sales are likely liquidity-driven following option exercises, not a bearish signal on the company's fundamentals.

Key Financial Metrics

Direction
selling
Total Value
$170.0K
Insiders
2

Key Facts

  • Two insiders sold a total of $170K in open-market sales over 7 days.
  • Director Welgus Howard G. exercised 8,192 derivative shares (cash outlay ~$32K) and sold 4,730 shares at $26.18 for $124K.
  • Total sales represent ~0.005% of ARQT's $3.2B market cap, immaterial by academic proportionality thresholds.
  • No C-suite executives participated in the selling; the cluster is limited to a director and a 'See Remarks' officer.
  • The derivative exercises and subsequent sales suggest liquidity/vesting-driven activity, not informed selling.

Financial Impact

Total insider sales of $170K, or ~0.005% of market cap, negligible economic impact.

insider ownership

Risk Factors

  • Insider sales could accelerate if the stock continues to appreciate, but current levels are routine.
  • No material risk identified from this cluster alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1787379288945

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 22, 2026